Rubius Therapeutics competitorsClear all

Rubius Therapeutics's top competitors include Atara Biotherapeutics and MedDay.

Save Comparison	Rubius Therapeutics Rubius is developing a new class of drugs, Red-Cell Therapeutics™.	Atara Biotherapeutics Atara Biotherapeutics is a drug development company focused on developing innovative therapies for patients with debilitating diseases.	MedDay MedDay is a biotechnology company specializing in therapeutics for the treatment of neuro-metabolic diseases.
Founding Date	Founding Date 2013	Founding Date 2012	Founding Date 2011
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Cambridge, US HQ Smithfield, US	Locations South San Francisco, US HQ Zug, CH Aurora, US New York, US Thousand Oaks, US	Locations Clichy, FR HQ Paris, FR Boston, US
Employees	Employees 17423% increase	Employees 39326% increase	Employees 6118% decrease
Valuation ($)	Valuation ($) 767.2 m	Valuation ($) 1.5 b	Valuation ($) N/A
Twitter followers	Twitter followers 1 k	Twitter followers 1.2 k	Twitter followers 229
Number of tweets (last 30 days)	Number of tweets (last 30 days) 11	Number of tweets (last 30 days) 4	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 5.3	Average likes per tweet (last 30 days) 11.5	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 339837	Alexa Website Rank 238554	Alexa Website Rank 399748
Employee Rating	Employee Rating N/A	Employee Rating 2.7	Employee Rating 3.1
Financial
Net income	Net income ($163.5m) (FY, 2019)	Net income ($291m) (FY, 2019)	Net income N/A
Funding
Total funding raised	Total funding raised $ 245m	Total funding raised $ 61.8m	Total funding raised $ 48.9m